Home › Funds › Jones Hill Capital LP › NGNE

Jones Hill Capital LP position in NGNE

NEUROGENE INC · Health Care

Jones Hill Capital LP reported holding 217,700 shares of NGNE (NEUROGENE INC) in its Q3 2026 13F filing — a position valued at US$6.1M, representing 1.03% of its reported portfolio and ranking #22 among its reported holdings. Jones Hill Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)217.70K sh
Reported value held$6.06M
Portfolio Weight1.03%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's NGNE position evolved

Jones Hill Capital LP first disclosed a stake in NGNE in Q3 2026 at 217,700 shares (US$6.1M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 217.70K $6.06M New

About NGNE and 13F data

NGNE (NEUROGENE INC) is a Health Care company. 40 other funds we track also report a position in NGNE — the largest reported positions include Samsara BioCapital, LLC (US$54.0M), Casdin Capital (US$48.6M), Redmile Group, LLC (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NGNE

All NGNE fund holders →

FAQ

How long has Jones Hill Capital LP held NGNE?

Jones Hill Capital LP has disclosed NGNE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Jones Hill Capital LP's current position in NGNE?

As of Q3 2026, Jones Hill Capital LP holds 217.70K shares of NGNE (NEUROGENE INC), valued at $6.06M, representing 1.03% of its reported portfolio and ranking #22.

Has Jones Hill Capital LP been buying or selling NGNE?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in NGNE.

Which other funds hold NGNE?

Other major institutional holders of NGNE include Samsara BioCapital, LLC, Casdin Capital, Redmile Group, LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.